🟢 Aperam is trading 4.3% up today after JPMorgan price target hike and reaffirmed guidance

Aperam is trading 4.3% up at €45.00 after JPMorgan lifted its price target and the company reaffirmed its mid-term financial outlook.

• JPMorgan raised its price target while maintaining a Hold rating, signaling improved analyst confidence in the company's trajectory.
• Management reaffirmed its Q2 2026 EBITDA guidance at levels significantly higher than Q1, providing clear visibility on operational growth.
• The confirmation of the 2026 base dividend framework continues to support the stock’s appeal for income-focused investors.